The controversial and never-proven-effective drug to treat Alzheimer's disease, aducanumab (Aduhelm) has been discontinued.
The first CRISPR-based therapy approval is a milestone worthy of noting.
An FDA advisory committee has concluded that phenylephrine, a popular decongestant in cough and cold remedies, is ineffective.
The FDA continues to permit the inclusion of an ineffective ingredient in hundreds of cough and cold products.
How a chance discovery by one scientist improved the safety of consumers worldwide.
The polypill is effective for secondary prevention of cardiovascular disease. By combining drugs in a single pill, it improves convenience and compliance.
Two pills and an injection are FDA-approved to prevent HIV infection. Not enough patients and providers know about them.
A new systematic review examines the evidence for zinc to prevent or treat respiratory tract infections.
There is the widespread belief that simply touching fentanyl can be fatal. This assumption isn't supported by science or evidence.
Melatonin use is increasing, and accelerated during the pandemic. Overdoses are also increasing in children, and in rare cases are linked to serious harms.